Scientific Team2018-09-06T13:07:41+00:00

Since the establishment of the CANSERCH research platform in pediatric oncology and hematology, 10 researchers from various origins and training backgrounds have been working in Geneva since 2011. This offers a “pooling” of professional researchers in one place for greater efficiency.

Professor Marc Ansari, Member
Founder and Director


Head of the Pediatric Onco-Hematology Unit HUG
Marc Ansari has practiced in the medical field for over 15 years, particularly in the areas of pediatric oncology-hematology and genetics. In 2011, he founded the CANSEARCH Foundation and research platform at the University of Geneva. Since 1 January 2013, he is Head of the Pediatric Onco-Hematology unit at the HUG. In November 2015, he was appointed Professor at the Faculty of Medicine of Geneva.
Frédéric Baleydier, MD, Ph.D

Frédéric Baleydier has benefiting from a training in onco-hematology and pediatric immunology carried out in France (IHOP, Hospices Civils de Lyon, Necker-Children-Sick Hospital, Assistance-Public Hospitals of Paris), supplemented by a scientific training in Paris and Boston in the USA (Brigham and Women's Hospital, Harvard Medical School).
He was a senior doctor in pediatric hemato-oncology in Lyon (IHOP, Hospices Civils de Lyon) and in the United Kingdom in Bristol (Bristol Royal Hospital for Children, Bristol University Hospitals) before joining the team of pediatric onco-hematology of HUG in September 2016
Dr. Fanette Bernard

Pediatric onco-hematologist in the HUG pediatric onco-hematology unit since 2012. Prior to this, Fanette trained and worked at the Timone-childrens hospital in Marseille, France. She is involved in clinical research in the field of hematopoietic stem cell transplantation.
Dr. Rao S. Chakradhara Uppugunduri, PhD, Indian, Geneva, Switzerland

Rao worked in the pediatric onco-hematology platform of the University Centre of Geneva (laboratory CANSEARCH Foundation) as a post-doc in the group of drug-oncogenetics. He specializes in pharmacology and pharmacogenetics.

Dr. Patricia Curtis, PhD, Geneva, Switzerland

Patricia followed a molecular geneticist training at King’s College in London. She is currently working as a postdoctoral researcher in the CANSEARCH Foundation laboratory. Her areas of particular interest involve the pharmacogenetics of childhood leukemia with the hope of finding biomarkers that are related to the mechanisms of action of current therapies and how they can be a predictor of treatment response.
Dr. Youssef Daali, PharmD, PhD. Pharmacist, Morocco, Switzerland

Head of the Clinical Research Laboratory of Pharmacology Service Geneva University Center, Youssef works in partnership with the pediatric onco-hematology platform of the University Centre of Geneva (laboratory of the CANSEARCH Foundation) in the areas of pediatric pharmacology.
Aneta Drakul

A young doctor from the University of Zurich, Aneta joined the CANSEARCH pediatric oncology and hematology research platform as part of her MD PhD, which she is doing in parallel with her clinical training at Kinderspital Zurich. She is involved in research in the field of pharmacogenetics; in particular, her work focuses on the influence of specific alleles on the toxicity of busulfan.
Benjamin Fernandez, student, Geneva, Switzerland

Benjamin is a student in Master of Human Medicine at the University of Geneva. He works on the CANSEARCH research platform in pediatric oncology and hematology under the responsibility of Prof. MarcAnsari and Dr. Patricia Curtis. His dissertation topic deals with the pharmacogenetics of childhood leukemia and the search for genetic markers that can influence the response to current treatments.
Hadrien Golay MSC MSc, Geneva, Switzerland

Hadrien obtained a Master's degree in Life Sciences and Technologies from EPFL, after a Master's degree in cancer immunotherapy at the Dana-Farber Cancer Institute in Boston. Currently a final year medical student at the University of Lausanne, he will join the CANSEARCH laboratory team as a MIMOSA fellow and medical doctorate (M.D.) in November 2018, for a research project in pharmacogenetics. He will then begin his clinical pediatrics training in November 2019.
Dr. Fabienne Gumy Pause, MD, Geneva, Switzerland.

Head of the oncogenetic group of the platform of hematology and pediatric oncology of the University Center of Geneva (laboratory of the CANSEARCH foundation). Hematologist-pediatric oncologist doctor at the Cantonal University Hospital of Geneva.
Simona Jurkovic Mlakar, PhD, MPharm, Slovenia

Simona is working as a postdoctoral researcher in the CANSEARCH laboratory. Before joining the CANSEARCH team, she worked as an assistant in the Biochemistry and Clinical Genetics Department of the Faculty of Pharmacy of the University of Ljubljana (Solvenia) and the Faculty of Medicine at Lund University (Sweden). She specializes in pharmacogenetics, clinical biochemistry and molecular biology.
Mary Khoshbeen – Boudal, Geneva, Switzerland

Mary is a graduate of the Geneva laboratory assistants school and works in the CANSEARCH laboratory as a laboratory assistant. She specializes in biochemistry and molecular biology.
Laurence Lesne, graduated in Biology at the University of Geneva, Geneva, Switzerland

Laurence worked in the pediatric onco-hematology platform of the University Centre of Geneva (laboratory CANSEARCH Foundation) as a laboratory assistant in the cancer genetics group. She specializes in cell culture, biochemistry and molecular biology.
Denis Marino, Geneva, Switzerland

Denis received his degree in Biomedical Technician ES analysis (TAB) at Locarno. He specialized in biochemistry, cytometry, immunology, mouse models of tumorigenèses and Biosafety Officers (BSO), he workes for the CANSEARCH Foundation laboratory as TAB.
Vid Mlakar, PhD, Slovenia

Vid earned a degree in molecular biology and biochemistry at the University of Ljubljana (Slovenia). He joined the CANSEARCH laboratory team as a postdoctoral researcher. He specializes in molecular biology and cancer genetics.
Dr Tiago NAVA, MD, PhD

A pediatric onco-hematologist, Tiago trained in Brazil in paediatrics and pediatric hematology. After a 3-year clinical fellowship in pediatric onco-hematology, in Montreal, Canada, he joined the HUG team as clinical assistant in July 2017. At the same time, he joined the CANSEARCH laboratory where he will continue his research Including the pharmacokinetics of agents used in stem cell transplantation, and studies of clinical, biological and genetic biomarkers of toxicity associated with these drugs.

Fanny Ouk, medical student, Geneva, Switzerland - 10 09 18

Fanny is a 6th year medical student at the University of Geneva who, through her affinity with pediatrics, has written as part of her master's work a literature review on the evaluation of the gonadotoxicity of oncological treatments used in pediatrics under the direction of Dr. Fabienne Gumy Pause. This document could serve as a decision aid for the medical teams involved in the preservation of fertility. Her work has thus contributed to the activities of the pediatric onco-hematology platform of the CANSEARCH Foundation.
Dr. André O. von Bueren, M.D., Ph.D., PD.

Responsible for the Pediatric Neuro-oncology group, a reference for children and adolescents with brain tumors and a hematologist-oncologist from the Pediatric Oncology and Hematology Unit of the HUG, André has been practicing in the medical field for almost 15 years. He is specialized in pediatric neuro-oncology. Her areas of interest include clinical trials and pre-clinical research of pediatric brain tumors, particularly high-grade gliomas.
Dr. Nicolas WAESPE, MD

Nicolas is a pediatrician, has worked in oncology-hematologic pediatrics in Switzerland and has completed his training with a clinical fellowship and research at SickKids Hospital in Toronto, Canada. Nicolas joined the CANSEARCH Research laboratory at the University of Geneva as a researcher in August 2018. In parallel, he is a collaborator at the Institute of Social and Preventive Medicine in Bern. His research projects aim to better understand the effect of genetic differences on the development of childhood cancers and the side effects after anti-cancer treatments.